Humacyte SG&A Expense (Quarterly) Analysis

Humacyte Inc (HUMA)

7.56 +0.53 (+7.54%) USD | NASDAQ | May 22, 16:00

7.57 +0.01 (+0.13%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2020. Upgrade now.

Date	Value
March 31, 2024	5.314M
December 31, 2023	6.002M
September 30, 2023	6.07M
June 30, 2023	3.084M
March 31, 2023	5.234M
December 31, 2022	5.833M
September 30, 2022	6.188M
June 30, 2022	5.18M

Date	Value
March 31, 2022	5.682M
December 31, 2021	5.554M
September 30, 2021	5.398M
June 30, 2021	5.391M
March 31, 2021	4.787M
December 31, 2020	2.597M
September 30, 2020	3.435M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

2.597M

Minimum

Dec 2020

6.188M

Maximum

Sep 2022

5.050M

Average

5.391M

Median

Jun 2021

SG&A Expense (Quarterly) Benchmarks